Outcome parameters | CV period n = 265 | AV period n = 265 | p |
---|---|---|---|
Primary outcome | |||
Time spent with SpO2 in the acceptable range—% of DNP duration* | 43 ± 37 (38–47) | 48 ± 37 (43–52) | 0.03 |
Secondary outcome | |||
Patients with SpO2 in the acceptable range during DNP—n (%)* | 123 (46%) | 160 (60%) | 0.001 |
Patients with at least one episode of: | |||
SpO2 ≤ 85%**—n (%) | 50 (19%) | 30 (11%) | 0.02 |
SpO2 < 90%**—n (%) | 92 (35%) | 69 (26%) | 0.03 |
Time spent with: | |||
SpO2 ≤ 85%—% of DNP duration | 3 ± 8 (2–4) | 2 ± 6 (1–2) | 0.03 |
SpO2 < 90%—% of DNP duration | 6 ± 11 (5–7) | 5 ± 12 (3–6) | 0.02 |
FiO2 100%—% of DNP duration | 6 ± 12 (4–7) | 4 ± 10 (3–6) | 0.09 |
SpO2 mean—% | 95 ± 3 (95–95) | 95 ± 3 (95–95) | 0.81 |
SpO2 min—% | 91 ± 6 (90–91) | 91 ± 8 (90–92) | 0.20 |
SpO2 max—% | 97 ± 2 (97–98) | 97 ± 2 (97–98) | 0.63 |